Market Cap 7.38M
Revenue (ttm) 5.31M
Net Income (ttm) -4.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -93.60%
Debt to Equity Ratio 0.00
Volume 9,969
Avg Vol 21,082
Day's Range N/A - N/A
Shares Out 3.09M
Stochastic %K 65%
Beta 0.28
Analysts Strong Sell
Price Target $9.00

Company Profile

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 645 2111
Fax: 949 553 1231
Address:
17571 Von Karman Avenue, Irvine, United States
DARKP00L
DARKP00L May. 28 at 12:40 PM
$BMRA 08:24 on May. 28 2026 Biomerica Enters Into Master Services Agreement With Confidential Life Sciences Company To Develop Proprietary IVD Assays; Engagement Carries Initial Contract Development Target Fee Of Over $1.75M #tradeideas
0 · Reply
focafoca99
focafoca99 May. 28 at 12:32 PM
$BMRA lands a $1.75 million CDMO master services agreement for diagnostic assay development.
0 · Reply
MrTicker
MrTicker May. 28 at 12:30 PM
$BMRA solid news, more volume and this breaks $3.. jmo
0 · Reply
MrTicker
MrTicker May. 28 at 12:25 PM
$BMRA Biomerica Enters Into Master Services Agreement With Confidential Life Sciences Company To Develop Proprietary IVD Assays; Engagement Carries Initial Contract Development Target Fee Of Over $1.75M BENZINGA 7:24 AM ET 5/28/2026
0 · Reply
MrTicker
MrTicker May. 28 at 12:20 PM
$BMRA Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic DevelopmentAuto-renewing Master Services Agreement engages Biomerica’s integrated development and manufacturing platform, reflecting the Company’s CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program GLOBENEWSWIRE 7:19 AM ET 5/28/2026
0 · Reply
Stock_Catcher
Stock_Catcher May. 28 at 12:19 PM
$BMRA Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Apr. 29 at 12:21 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomericas-inFoods-IBS-Data-Accepted-for-Presentation-at-Digestive-Disease-Week-2026/default.aspx
0 · Reply
PenkeInvesting
PenkeInvesting Apr. 19 at 2:36 AM
Fundamental analysis of $BMRA (BIOMERICA INC) based on financial data and reported results. #BMRA #BIOMERICA
0 · Reply
Tahadicaprio
Tahadicaprio Apr. 17 at 11:07 AM
1 · Reply
Tahadicaprio
Tahadicaprio Apr. 17 at 9:46 AM
0 · Reply
Latest News on BMRA
Biomerica Reports Third Quarter Fiscal 2026 Financial Results

Apr 13, 2026, 6:57 PM EDT - 7 weeks ago

Biomerica Reports Third Quarter Fiscal 2026 Financial Results


Biomerica receives first commercial order for Hp Detect

2026-03-18T12:37:33.000Z - 2 months ago

Biomerica receives first commercial order for Hp Detect


Biomerica receives MHRA registration for hp+detect

2026-03-05T13:37:21.000Z - 3 months ago

Biomerica receives MHRA registration for hp+detect


Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Jan 14, 2026, 5:17 PM EST - 4 months ago

Biomerica Reports Second Quarter Fiscal 2026 Financial Results


Biomerica expands CDMO services to meet growing market demand

2025-11-06T13:46:26.000Z - 7 months ago

Biomerica expands CDMO services to meet growing market demand


Biomerica reports Q1 EPS 0c vs. (8c) last year

2025-10-15T13:30:20.000Z - 8 months ago

Biomerica reports Q1 EPS 0c vs. (8c) last year


Biomerica Reports First Quarter Fiscal 2026 Financial Results

Oct 15, 2025, 9:27 AM EDT - 8 months ago

Biomerica Reports First Quarter Fiscal 2026 Financial Results


Biomerica appoints Gary Huff to board of directors

2025-10-08T12:30:43.000Z - 8 months ago

Biomerica appoints Gary Huff to board of directors

LH


Biomerica Reports Fiscal 2025 Year End Results

Aug 29, 2025, 5:12 PM EDT - 9 months ago

Biomerica Reports Fiscal 2025 Year End Results


Biomerica announces inFoods IBS received CPT PLA code

2025-07-02T12:16:08.000Z - 1 year ago

Biomerica announces inFoods IBS received CPT PLA code


Biomerica Announces Reverse Stock Split

Apr 16, 2025, 9:00 AM EDT - 1 year ago

Biomerica Announces Reverse Stock Split


Biomerica Reports First Quarter Fiscal 2025 Financial Results

Oct 16, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports First Quarter Fiscal 2025 Financial Results


Biomerica Reports Fiscal 2024 Year End Results

Aug 29, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports Fiscal 2024 Year End Results


Biomerica provides update on inFoods® IBS expansion

Apr 15, 2024, 7:47 AM EDT - 2 years ago

Biomerica provides update on inFoods® IBS expansion


Biomerica Reports Third Quarter 2024 Financial Results

Apr 12, 2024, 7:23 PM EDT - 2 years ago

Biomerica Reports Third Quarter 2024 Financial Results


Biomerica Reports Second Quarter 2024 Financial Results

Jan 16, 2024, 8:19 AM EST - 2 years ago

Biomerica Reports Second Quarter 2024 Financial Results


DARKP00L
DARKP00L May. 28 at 12:40 PM
$BMRA 08:24 on May. 28 2026 Biomerica Enters Into Master Services Agreement With Confidential Life Sciences Company To Develop Proprietary IVD Assays; Engagement Carries Initial Contract Development Target Fee Of Over $1.75M #tradeideas
0 · Reply
focafoca99
focafoca99 May. 28 at 12:32 PM
$BMRA lands a $1.75 million CDMO master services agreement for diagnostic assay development.
0 · Reply
MrTicker
MrTicker May. 28 at 12:30 PM
$BMRA solid news, more volume and this breaks $3.. jmo
0 · Reply
MrTicker
MrTicker May. 28 at 12:25 PM
$BMRA Biomerica Enters Into Master Services Agreement With Confidential Life Sciences Company To Develop Proprietary IVD Assays; Engagement Carries Initial Contract Development Target Fee Of Over $1.75M BENZINGA 7:24 AM ET 5/28/2026
0 · Reply
MrTicker
MrTicker May. 28 at 12:20 PM
$BMRA Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic DevelopmentAuto-renewing Master Services Agreement engages Biomerica’s integrated development and manufacturing platform, reflecting the Company’s CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program GLOBENEWSWIRE 7:19 AM ET 5/28/2026
0 · Reply
Stock_Catcher
Stock_Catcher May. 28 at 12:19 PM
$BMRA Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Apr. 29 at 12:21 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomericas-inFoods-IBS-Data-Accepted-for-Presentation-at-Digestive-Disease-Week-2026/default.aspx
0 · Reply
PenkeInvesting
PenkeInvesting Apr. 19 at 2:36 AM
Fundamental analysis of $BMRA (BIOMERICA INC) based on financial data and reported results. #BMRA #BIOMERICA
0 · Reply
Tahadicaprio
Tahadicaprio Apr. 17 at 11:07 AM
1 · Reply
Tahadicaprio
Tahadicaprio Apr. 17 at 9:46 AM
0 · Reply
Tahadicaprio
Tahadicaprio Apr. 16 at 10:06 PM
$ASTI They are controlling the price and the daily short percentage is high,,,, potential is here $BMRA
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Apr. 16 at 4:12 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomerica-Announces-Medicare-Administrative-Contractor-Confirmation-of-Individual-Claim-Review-for-inFoods-IBS-Opening-a-Scalable-Medicare-Commercialization-Pathway/default.aspx
0 · Reply
DARKP00L
DARKP00L Apr. 16 at 1:29 PM
$BMRA 08:21 on Apr. 16 2026 Biomerica's Ethos Laboratories' Test Now Eligible For Medicare Coverage On Individual Basis Announced By Medicare Administrative Contractor #tradeideas
0 · Reply
MMCGON333
MMCGON333 Apr. 16 at 12:47 PM
$BMRA Everytime there is good news it goes down more
1 · Reply
Stock_Catcher
Stock_Catcher Apr. 16 at 12:19 PM
$BMRA Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
0 · Reply
nyg123
nyg123 Apr. 15 at 2:56 PM
$BMRA Glad to see the CFO was finally terminated! He thought he could save his way to success. Need a CFO focused on REVENUE growth versus cost cutting.
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Apr. 14 at 3:02 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomerica-Launches-inFoods-IBS-in-Canada-Through-Partnerships-with-Phoenix-Airmid-Biomedical-and-CanAlt-Health-Labs/default.aspx
0 · Reply
ildamiano1
ildamiano1 Apr. 14 at 12:57 PM
$BMRA CFO Gary Lu finally leaving - there’s half a million dollars per year saved off the bat going forward 🎉🎉 Federal final approval for the USD300 inFoods subsidy still awaited - this will be a gamechanger when it comes as it will make the product free for anyone with Medicaid.
0 · Reply
LewisDaKat
LewisDaKat Mar. 18 at 7:30 PM
$BMRA Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect(TM)) from One of the Largest Clinical Laboratory Chains in Europe https://marketwirenews.com/stock/bmra/news/biomerica-receives-first-commercial-order-for-its-h--4974515943106797.html?utm_source=stocktwits
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Mar. 18 at 12:31 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomerica-Receives-First-Commercial-Order-for-its-H--pylori-test-Hp-Detect-from-One-of-the-Largest-Clinical-Laboratory-Chains-in-Europe/default.aspx
0 · Reply
DARKP00L
DARKP00L Mar. 18 at 12:21 PM
$BMRA 08:21 on Mar. 18 2026 Biomerica Receives First Commercial Order For Hp Detect, Helicobacter Pylori Diagnostic Stool Antigen Test #tradeideas
0 · Reply
Stock_Catcher
Stock_Catcher Mar. 18 at 12:19 PM
$BMRA ​​BMRA Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe
0 · Reply